Acute inflammatory demyelinating polyneuropathy shortly after administration of intravitreal ranibizumab

Neurologia (Engl Ed). 2023 May;38(4):309-311. doi: 10.1016/j.nrleng.2022.04.004.
No abstract available

Publication types

  • Letter

MeSH terms

  • Guillain-Barre Syndrome*
  • Humans
  • Ranibizumab* / adverse effects

Substances

  • Ranibizumab